MedPath

Effect of Nimbadi Gel and Nimbadi Taila in Dushta Vrana

Not yet recruiting
Conditions
Non-pressure chronic ulcer of skin, not elsewhere classified,
Registration Number
CTRI/2020/08/027219
Lead Sponsor
National Institute of Ayurveda
Brief Summary

*Shalya Tantra* is one of important branch of *Ayurveda.**Vrana* is a very common clinical entity present with various signs and symptoms and create a great problem in surgical practice. *Dushta Vrana* is atypical non-healing ulcer which refuses to heal. In present study, local application of *anubhoot yogas,*  *Nimbadi* Geland *Nimbadi* *Taila* on *Vrana* for the management has been planned. Ingredients of *Nimbadi* Gel and *Nimbadi Taila* are same. In present study, 30 patients will be selected from OPD and IPD of PG Department of *Shalya Tantra*, National Institute of *Ayurveda,* *Jaipur* and patient randomly divided into 2 groups of 15 patients each, on the basis of inclusion and exclusion criteria. The patient will be treated with local application of *Nimbadi* Gel on *Dushta Vrana* in Group A and with *Nimbadi Taila* in Group B, up to 4 weeks, then compare the effect between *Nimbadi* Geland *Nimbadi Taila***.**

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1 patients aged between 16-60 years 2 patients should fulfil the diagnostic criteria based on sign and symptoms of dushta vrana.

Exclusion Criteria
  • 1 Patients more than 60 years and less than 16 years of age 2 Patient who has suffering from any wound which is related to systemic diseases like – Tubercular wound, Leprotic wound, Syphilitic wound etc.
  • 3 Wound related to burn 4 Any malignant wound.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Moderate improvement 51-75%after 4 week
Marked improvement 76-90%after 4 week
Mild improvement 26- 50%after 4 week
No improvement or less then 25%after 4 week
Cured 90% relief in sign and symptoms and no recurrence during follow upafter 4 week
Secondary Outcome Measures
NameTimeMethod
Aggravation of symptomsafter 2 weeks

Trial Locations

Locations (1)

National Institute of Ayurveda Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda Jaipur
🇮🇳Jaipur, RAJASTHAN, India
Dr Indrabir Mishra
Principal investigator
8770376486
imveer03@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.